| Monday, June 23, 2025 Symposium 3 ROOM 3 (F6) | Ground Floor 09:10h – 10:25h CRS CONSERVATIVE
Real world evidence in biological therapy for CRSwNP
|
| Chair: Ludger Klimek |
| Long-term outcomes of dupilumab-treated CRSwNP |
| Stefania Gallo |
| Blocking IL-5 signaling in CRSwNP: from RCTs to Real-World Evidence |
| Philippe Gevaert |
| The value of eosinophils for the indication and follow-up of biological therapy |
| Josje Otten |
| The role of comorbidities in biological efficacy |
| Anju Peters |
| New evidence of biological efficacy with emphasis on olfaction |
| Joaquim Mullol |
